|
2017 Journal Article Low-volume high-intensity interval training is sufficient to ameliorate the severity of metabolic syndromeRamos, Joyce S., Dalleck, Lance C., Borrani, Fabio, Beetham, Kassia S., Wallen, Matthew P., Mallard, Alistair R., Clark, Bronwyn, Gomersall, Sjaan, Keating, Shelley E., Fassett, Robert G. and Coombes, Jeff S. (2017). Low-volume high-intensity interval training is sufficient to ameliorate the severity of metabolic syndrome. Metabolic Syndrome and Related Disorders, 15 (7), 319-328. doi: 10.1089/met.2017.0042 |
|
2017 Journal Article High-intensity interval training and cardiac autonomic control in individuals with metabolic syndrome: A randomised trialRamos, Joyce S., Dalleck, Lance C., Borrani, Fabio, Beetham, Kassia S., Mielke, Gregore Iven, Dias, Katrin A., Wallen, Matthew P., Keating, Shelley E., Fassett, Robert G. and Coombes, Jeff S. (2017). High-intensity interval training and cardiac autonomic control in individuals with metabolic syndrome: A randomised trial. International Journal of Cardiology, 245, 245-252. doi: 10.1016/j.ijcard.2017.07.063 |
|
2017 Journal Article CKD.QLD: establishment of a chronic kidney disease [CKD] registry in Queensland, AustraliaVenuthurupalli, Sree K., Hoy, Wendy E., Healy, Helen G., Cameron, Anne and Fassett, Robert G. (2017). CKD.QLD: establishment of a chronic kidney disease [CKD] registry in Queensland, Australia. BMC Nephrology, 18 (1) 189, 189. doi: 10.1186/s12882-017-0607-5 |
|
2017 Journal Article Human skeletal muscle plasmalemma alters its structure to change its Ca2+-handling following heavy-load resistance exerciseCully, Tanya R., Murphy, Robyn M., Roberts, Llion, Raastad, Truls, Fassett, Robert G., Coombes, Jeff S., Jayasinghe, Isuru D. and Launikonis, Bradley S. (2017). Human skeletal muscle plasmalemma alters its structure to change its Ca2+-handling following heavy-load resistance exercise. Nature Communications, 8 (1) 14266, 14266.1-14266.10. doi: 10.1038/ncomms14266 |
|
2016 Journal Article The effect of different volumes of high-intensity interval training on proinsulin in participants with the metabolic syndrome: a randomised trialRamos, Joyce S., Dalleck, Lance C., Borrani, Fabio, Mallard, Alistair R., Clark, Bronwyn, Keating, Shelley E., Fassett, Robert G. and Coombes, Jeff S. (2016). The effect of different volumes of high-intensity interval training on proinsulin in participants with the metabolic syndrome: a randomised trial. Diabetologia, 59 (11), 1-13. doi: 10.1007/s00125-016-4064-7 |
|
2016 Journal Article Fitness is independently associated with central hemodynamics in metabolic syndromeRamos, J.S., Ramos, M.V., Dalleck, L.C., Borrani, F., Walker, K.B., Fassett, R.G., Sharman, J.E. and Coombes, J.S. (2016). Fitness is independently associated with central hemodynamics in metabolic syndrome. Medicine and Science in Sports and Exercise, 48 (8), 1539-1547. doi: 10.1249/MSS.0000000000000916 |
|
2016 Journal Article 12min/week of high-intensity interval training reduces aortic reservoir pressure in individuals with metabolic syndrome: a randomized trialRamos, Joyce S., Dalleck, Lance C., Ramos, Maximiano V., Borrani, Fabio, Roberts, Llion, Gomersall, Sjaan, Beetham, Kassia S., Dias, Katrin A., Keating, Shelley E., Fassett, Robert G., Sharman, James E. and Coombes, Jeff S. (2016). 12min/week of high-intensity interval training reduces aortic reservoir pressure in individuals with metabolic syndrome: a randomized trial. Journal of Hypertension, 34 (10), 1977-1987. doi: 10.1097/HJH.0000000000001034 |
|
2016 Journal Article A novel hypoxia-inducible factor-prolyl hydroxylase inhibitor (GSK1278863) for anemia in CKD: a 28-day, phase 2A randomized trialBrigandi, Richard A., Johnson, Brendan, Oei, Coreen, Westerman, Mark, Olbina, Gordana, De Zoysa, Janak, Roger, Simon D., Sahay, Manisha, Cross, Nicholas, McMahon, Lawrence, Guptha, Veerabhadra, Smolyarchuk, Elena A., Singh, Narinder, Russ, Steven F., Kumar, Sanjay, Borsukov, Alexey V., Marasaev, Vyacheslav V., Prasad, Gullipalli, Timokhovskaya, Galina Y., Kolmakova, Elena V., Dobronravov, Vladimir A., Zakharova, Elena V., Abraham, Georgi, Packham, David, Zateyshchikov, Dmitry A., Arutyunov, Gregory P., Volgina, Galina V., Lipatov, Kirill S., Perlin, Dmitry V. ... Lysenko, Lidia V. (2016). A novel hypoxia-inducible factor-prolyl hydroxylase inhibitor (GSK1278863) for anemia in CKD: a 28-day, phase 2A randomized trial. American Journal of Kidney Diseases, 67 (6), 861-871. doi: 10.1053/j.ajkd.2015.11.021 |
|
2016 Journal Article Cardiorespiratory fitness is positively associated with increased pancreatic beta cell function independent of fatness in individuals with the metabolic syndrome: Fitness versus fatnessRamos, Joyce S., Dalleck, Lance C., Borrani, Fabio, Fassett, Robert G. and Coombes, Jeff S. (2016). Cardiorespiratory fitness is positively associated with increased pancreatic beta cell function independent of fatness in individuals with the metabolic syndrome: Fitness versus fatness. Journal of Science and Medicine in Sport, 20 (1), 45-49. doi: 10.1016/j.jsams.2016.04.007 |
|
2016 Journal Article Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney diseaseTong, Allison, Tunnicliffe, David J., Lopez-Vargas, Pamela, Mallett, Andrew, Patel, Chirag, Savige, Judy, Campbell, Katrina, Patel, Manish, Tchan, Michel C., Alexander, Stephen I., Lee, Vincent, Craig, Jonathan C., Fassett, Robert and Rangan, Gopala K. (2016). Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease. Nephrology, 21 (2), 122-132. doi: 10.1111/nep.12579 |
|
2016 Journal Article Sulforaphane and other nutrigenomic Nrf2 activators: can the clinician's expectation be matched by the reality?Houghton, Christine A., Fassett, Robert G. and Coombes, Jeff S. (2016). Sulforaphane and other nutrigenomic Nrf2 activators: can the clinician's expectation be matched by the reality?. Oxidative Medicine and Cellular Longevity, 2016 (7857186) 7857186, 1-17. doi: 10.1155/2016/7857186 |
|
2016 Journal Article Astaxanthin has no effect on arterial stiffness, oxidative stress, or inflammation in renal transplant recipients: a randomized controlled trial (the XANTHIN trial)Coombes, Jeff S., Sharman, James E. and Fassett, Robert G. (2016). Astaxanthin has no effect on arterial stiffness, oxidative stress, or inflammation in renal transplant recipients: a randomized controlled trial (the XANTHIN trial). The American Journal of Clinical Nutrition, 103 (1), 283-289. doi: 10.3945/ajcn.115.115477 |
|
2015 Journal Article Biomarkers of drug-induced acute kidney injury in the adultGobe, Glenda C., Coombes, Jeff S., Fassett, Robert G. and Endre, Zoltan H. (2015). Biomarkers of drug-induced acute kidney injury in the adult. Expert Opinion on Drug Metabolism and Toxicology, 11 (11), 1683-1694. doi: 10.1517/17425255.2015.1083011 |
|
2015 Journal Article Endogenously elevated bilirubin modulates kidney function and protects from circulating oxidative stress in a rat model of adenine-induced kidney failureBoon, Ai-Ching, Lam, Alfred K., Gopalan, Vinod, Benzie, Iris F., Briskey, David, Coombes, Jeff S., Fassett, Robert G. and Bulmer, Andrew C. (2015). Endogenously elevated bilirubin modulates kidney function and protects from circulating oxidative stress in a rat model of adenine-induced kidney failure. Scientific Reports, 5 (15482) 15482, 1-16. doi: 10.1038/srep15482 |
|
2015 Journal Article Effects of atorvastatin on oxidative stress in chronic kidney diseaseFassett, Robert G., Robertson, Iain K., Ball, Madeleine J., Geraghty, Dominic P. and Coombes, Jeff S. (2015). Effects of atorvastatin on oxidative stress in chronic kidney disease. Nephrology, 20 (10), 697-705. doi: 10.1111/nep.12502 |
|
2015 Journal Article Optimal criteria and sampling interval to detect a VO2 plateau at VO2max in patients with metabolic syndromeThomson, Amara C., Ramos, Joyce S., Fassett, Robert G., Coombes, Jeff S. and Dalleck, Lance C. (2015). Optimal criteria and sampling interval to detect a VO2 plateau at VO2max in patients with metabolic syndrome. Research in Sports Medicine: An International Journal, 23 (4), 337-350. doi: 10.1080/15438627.2015.1076411 |
|
2015 Journal Article Hydration and endocrine responses to intravenous fluid and oral glycerolvan Rosendal, S. P., Strobel, N. A., Osborne, M. A., Fassett, R. G. and Coombes, J. S. (2015). Hydration and endocrine responses to intravenous fluid and oral glycerol. Scandinavian Journal of Medicine and Science in Sports, 25 (S1), 112-125. doi: 10.1111/sms.12367 |
|
2015 Journal Article Voluntary exercise decreases atherosclerosis in nephrectomised ApoE knockout miceShing, Cecilia M., Fassett, Robert G., Peake, Jonathan M. and Coombes, Jeff S. (2015). Voluntary exercise decreases atherosclerosis in nephrectomised ApoE knockout mice. PLoS One, 10 (3) e0120287, e0120287. doi: 10.1371/journal.pone.0120287 |
|
2015 Journal Article 'Exercise Is Medicine': curbing the burden of chronic disease and physical inactivityCoombes, Jeff S,, Law, Jen, Lancashire, Bill and Fassett, Robert G. (2015). 'Exercise Is Medicine': curbing the burden of chronic disease and physical inactivity. Asia-Pacific Journal of Public Health, 27 (2), NP600-NP605. doi: 10.1177/1010539513481492 |
|
2015 Journal Article A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the handling erythropoietin resistance with oxpentifylline (HERO) trialJohnson, David W., Pascoe, Elaine M., Badve, Sunil V., Dalziel, Kim, Cass, Alan, Clarke, Philip, Ferrari, Paolo, McDonald, Stephen P., Morrish, Alicia T., Pedagogos, Eugenie, Perkovic, Vlado, Reidlinger, Donna, Scaria, Anish, Walker, Rowan, Vergara, Liza A., Hawley, Carmel M., on behalf of the HERO Study Collaborative Group and Fassett, Rob (2015). A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the handling erythropoietin resistance with oxpentifylline (HERO) trial. American Journal of Kidney Diseases, 65 (1), 49-57. doi: 10.1053/j.ajkd.2014.06.020 |
